Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £1.25 million

25 Jan 2011 07:00

RNS Number : 9952Z
ViaLogy PLC
25 January 2011
 



 

ViaLogy PLC ("ViaLogy" or "the Company")

Placing to raise £1.25 million

London, January 25, 2011. ViaLogy (LSE:VIY) is pleased to announce that it has today raised £1.25 million through the placing of 41,666,664 new ordinary shares of 1p each ("Placing Shares") at a price of 3p per share with certain existing shareholders ("the Placing").

The net proceeds of the Placing will be used in the further expansion of ViaLogy's energy business which uses its proprietary QuantumRD™ technology to discover and characterise hydrocarbon reservoirs and generate drilling targets.

Application has been made for the 41,666,664 Placing Shares to be admitted to trading on AIM and dealings are expected to commence on 31 January 2011. Following the Placing, the total number of ordinary shares in issue and therefore the total number of voting rights is 733,941,998.

Terry Bond, chairman of ViaLogy commented: "This funding will help to provide a firm financial base during what promises to be a very important year for the company. At the beginning of 2010, and with our previous series of successful wells in Texas as a launching pad, the board took a deliberate decision to focus our attention on global E&P companies as the path to establish QuantumRD, a novel realisation of seismic interferometry, as a standard industry platform. This, we believe, is where the commercial future of our company lies.

"The new funds will permit some expansion of our capacity to meet anticipated contract demand for new offshore prospects in the near term. As previously announced, we have made significant progress in the past twelve months in gaining the acceptance of a new technology in the upstream E&P sector. We concluded a Master Services contract with a supermajor and are working on our first project for them; in addition, following successful completion of a technology demonstration project, we are in advanced talks with a Fortune Global 100 international E&P firm. Other talks are underway with a non-US national oil company. The discussions focus on large core projects, both onshore and offshore, which we expect will lead to commercial contracts. We have also received enquiries from some of the large international oilfield services firms, and we are in advanced discussions with one of them in relation to a possible strategic partnership." 

Options Grant

Under the terms of his employment contract entered into on June 22nd, 2010, Dr. Sandeep Gulati, ViaLogy's founder and Chief Technology Officer, is entitled to additional options awards in order to retain his interest in the ordinary share capital of ViaLogy. The Company has therefore issued 3,967,360 options exercisable at 1p per share. 

For further information please contact:

 

ViaLogy PLC 

 

 

 

 

 

Terry Bond, Chairman - UK & Europe

 

+44 (0) 1235 834734

 

 

 

 

 

 

Seymour Pierce Limited

Nominated Advisor and Broker to ViaLogy

 

 

 

 

 

Mark Percy / Catherine Leftley

(Corporate Finance)

Katie Ratner/Jeremy Stephenson

(Corporate Broking)

 

+44 (0) 207 107 8000

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUSSNRASAAUAR
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.